Bahareh Hajikhani Selected Research

Bahareh Hajikhani Research Topics

7	Infections 01/2022 - 01/2018
2	COVID-19 01/2021 - 01/2021
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 10/2020
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2022
1	Bacillary Dysentery (Shigellosis) 01/2022
1	Wounds and Injuries (Trauma) 11/2021
1	Inflammation (Inflammations) 01/2021
1	Insulin Resistance 01/2021
1	Skin Manifestations 01/2021
1	Neoplasms (Cancer) 10/2020
1	Clostridium Infections 04/2018
1	Diarrhea 04/2018

5	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2018
2	Tigecycline (Tygacil)FDA Link 11/2021 - 01/2021
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Colistin (Coly-Mycin)FDA Link 01/2022
1	Pyrazinamide FDA LinkGeneric 01/2022
1	homocysteine-thiolactone-nicotinamide (ST 22)IBA 11/2021
1	Linezolid (Zyvox)FDA Link 01/2021
1	Angiotensin-Converting Enzyme 2IBA 01/2021
1	Fusidic Acid (Fucithalmic)IBA 01/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Metformin (Glucophage)FDA LinkGeneric 01/2021
1	Methicillin (Metin)FDA Link 01/2021
1	Recombinant ProteinsIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	CytokinesIBA 01/2021
1	Daptomycin FDA Link 01/2021
1	Cyclin D1IBA 10/2020
1	NisinIBA 10/2020
1	Mupirocin (Bactroban)FDA LinkGeneric 01/2020

1	Length of Stay 01/2021